Edition:
United States

Accuray Inc (ARAY.O)

ARAY.O on Nasdaq

5.46USD
27 Jul 2016
Change (% chg)

$-0.01 (-0.18%)
Prev Close
$5.47
Open
$5.47
Day's High
$5.48
Day's Low
$5.40
Volume
206,403
Avg. Vol
634,264
52-wk High
$7.54
52-wk Low
$4.75

Latest Key Developments (Source: Significant Developments)

Accuray receives 510(K) FDA clearance for image-guided radiation therapy
Monday, 27 Jun 2016 06:30am EDT 

Accuray: Accuray receives 510(k) FDA clearance for the Radixact image-guided radiation therapy platform and integrated software .Will initiate commercial release of Radixact system late in Q1 of fiscal year 2017.  Full Article

Accuray sees FY 2016 backlog about $405 mln
Tuesday, 24 May 2016 04:23pm EDT 

Accuray Inc :Accuray Inc sees FY 2016 backlog about $405 million - SEC filing.  Full Article

Accuray Inc Reaffirms FY 2016 guidance
Thursday, 28 Jan 2016 04:03pm EST 

Accuray Inc:Reaffirmed previously provided financial guidance For Fy 2016.Says Fy 2016 Total revenue is expected to be between $395 million to $410 million and adjusted EBITDA is expected to range between $25 million to $35 million.Accuray continues to expect Fy 2016 gross orders for Fy 2016 will be approximately $295 million, which would represent a 10 percent increase year over year.  Full Article

Accuray Inc announces repurchases of convertible debt
Tuesday, 19 Jan 2016 06:00am EST 

Accuray Inc:Announces repurchases of convertible debt.Repurchased about $63.4 million in principal amount of 3.75% convertible senior notes due August 2016 for $66.6 million in cash.  Full Article

Accuray Inc closes $70 million straight debt financing
Tuesday, 12 Jan 2016 06:30am EST 

Accuray Inc:Closes $70 million straight debt financing.Says net proceeds of loan to be used, in addition to $30 million of cash funded by Accuray, to retire $100 million of convertible notes.  Full Article

Accuray Inc Reaffirms FY 2016 guidance
Thursday, 29 Oct 2015 04:01pm EDT 

Accuray Inc:Reaffirms its financial guidance for FY 2016 on total revenue of $395 million to $410 million and adjusted EBITDA of $25 million to $35 million.FY 2016 revenue of $402 million - Thomson Reuters I/B/E/S.  Full Article

Accuray Inc names Kevin Waters as CFO
Tuesday, 15 Sep 2015 04:05pm EDT 

Accuray Inc:Kevin Waters named CFO of Accuray.Says lichtwardt will continue in a consulting role with the company for an interim period.Kevin waters succeeds Gregory E. Lichtwardt.Says waters joined Accuray as its senior vice president, Finance, in October, 2013.  Full Article

Accuray Incorporated gives FY 2016 guidance; EBITDA guidance above analysts' estimates
Thursday, 20 Aug 2015 04:01pm EDT 

Accuray Incorporated:Expects FY 2016 revenue to be in the range of $395 million to $410 million.Expects FY 2016 adjusted EBITDA to be in the range of $25 million to $35 million.FY 2016 revenue of $408 million and EBITDA of $10 million - Thomson Reuters I/B/E/S.  Full Article

Accuray Incorporated and RaySearch announces long term collaboration agreement regarding RayCare oncology information system
Monday, 13 Jul 2015 05:30am EDT 

Accuray Incorporated:Says that the company and RaySearch Laboratories AB (publ) announced they have signed a long term collaboration agreement which will allow Accuray to co-market and offer the RayCare oncology information system (OIS) which is currently in development at RaySearch.Says under the contract, Accuray will have the opportunity to offer RayCare in several designated major radiation therapy markets, making available a fully-integrated solution with the TomoTherapy and CyberKnife System product portfolios.RaySearch, known for its treatment planning software, RayStation and Accuray, recognized for tumor treatments.  Full Article

Accuray Inc Signs agreement with MIM Software Inc to develop adaptive therapy software
Thursday, 30 Apr 2015 04:03pm EDT 

Accuray Inc:Signs agreement with MIM Software Inc to develop adaptive therapy software for TomoTherapy and CyberKnife product portfolios.Says new software solution will leverage both Accuray and MIM technology.  Full Article

BRIEF-Accuray receives 510(K) FDA clearance for image-guided radiation therapy

* Accuray receives 510(k) FDA clearance for the Radixact image-guided radiation therapy platform and integrated software